163 related articles for article (PubMed ID: 1968955)
21. Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain.
Reches A; Wagner HR; Barkai AI; Jackson V; Yablonskaya-Alter E; Fahn S
Psychopharmacology (Berl); 1984; 83(2):155-8. PubMed ID: 6431465
[TBL] [Abstract][Full Text] [Related]
22. Elevation of circulating prolactin concentrations may not cause striatal dopamine receptor supersensitivity.
Rupniak N; Hong M; Mansfield S; Fleminger S; Dyer R; Jenner P; Marsden CD
Eur J Pharmacol; 1983 Sep; 93(3-4):195-200. PubMed ID: 6139285
[TBL] [Abstract][Full Text] [Related]
23. Dopamine D1 receptor stimulation but not dopamine D2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor up-regulation.
Marin C; Chase TN
Eur J Pharmacol; 1993 Feb; 231(2):191-6. PubMed ID: 8095897
[TBL] [Abstract][Full Text] [Related]
24. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
25. Effect of haloperidol on expression of dopamine D2 receptor mRNAs in rat brain.
Srivastava LK; Morency MA; Bajwa SB; Mishra RK
J Mol Neurosci; 1990; 2(3):155-61. PubMed ID: 1703431
[TBL] [Abstract][Full Text] [Related]
26. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
[TBL] [Abstract][Full Text] [Related]
27. Differential alteration in striatal dopaminergic and cortical serotonergic receptors induced by repeated administration of haloperidol or centbutindole in rats.
Gulati A; Srimal RC; Dhawan BN
Pharmacology; 1988; 36(6):396-404. PubMed ID: 2901759
[TBL] [Abstract][Full Text] [Related]
28. Repeated aripiprazole treatment causes dopamine D2 receptor up-regulation and dopamine supersensitivity in young rats.
Varela FA; Der-Ghazarian T; Lee RJ; Charntikov S; Crawford CA; McDougall SA
J Psychopharmacol; 2014 Apr; 28(4):376-86. PubMed ID: 24045880
[TBL] [Abstract][Full Text] [Related]
29. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
30. Investigation of striatal dopamine D2 receptor acquisition following prenatal neuroleptic exposure.
Schmidt MH; Lee T
Psychiatry Res; 1991 Mar; 36(3):319-28. PubMed ID: 1676523
[TBL] [Abstract][Full Text] [Related]
31. Effects of pertussis toxin on behavioral responses during different withdrawal periods from chronic cocaine treatment.
Ushijima I; Mizuki Y; Kobayashi T; Aoki T; Suetsugi M; Usami K; Watanabe Y
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Nov; 24(8):1369-77. PubMed ID: 11125860
[TBL] [Abstract][Full Text] [Related]
32. Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: a quantitative in situ hybridization study.
Bernard V; Le Moine C; Bloch B
Neuroscience; 1991; 45(1):117-26. PubMed ID: 1754061
[TBL] [Abstract][Full Text] [Related]
33. Dopamine D2(High) receptors moderately elevated by sertindole.
Seeman P
Synapse; 2008 May; 62(5):389-93. PubMed ID: 18293356
[TBL] [Abstract][Full Text] [Related]
34. Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.
Janowsky A; Neve KA; Kinzie JM; Taylor B; de Paulis T; Belknap JK
J Pharmacol Exp Ther; 1992 Jun; 261(3):1282-90. PubMed ID: 1534844
[TBL] [Abstract][Full Text] [Related]
35. Minimal brain damage induced by early iron deficiency: modified dopaminergic neurotransmission.
Youdim MB; Ben-Shachar D
Isr J Med Sci; 1987; 23(1-2):19-25. PubMed ID: 3032848
[TBL] [Abstract][Full Text] [Related]
36. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
[TBL] [Abstract][Full Text] [Related]
37. A new animal model of dopamine supersensitivity using s.c. implantation of haloperidol releasing polymers.
Köhler U; Schröder H; Augustin W; Sabel BA
Neurosci Lett; 1994 Mar; 170(1):99-102. PubMed ID: 8041522
[TBL] [Abstract][Full Text] [Related]
38. 5-HT2 receptors modulate the expression of antipsychotic-induced dopamine supersensitivity.
Charron A; Hage CE; Servonnet A; Samaha AN
Eur Neuropsychopharmacol; 2015 Dec; 25(12):2381-93. PubMed ID: 26508706
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of dopamine D2 receptor mRNA in rat striatum by chronic neuroleptic treatment.
Rogue P; Hanauer A; Zwiller J; Malviya AN; Vincendon G
Eur J Pharmacol; 1991 Jun; 207(2):165-8. PubMed ID: 1679015
[TBL] [Abstract][Full Text] [Related]
40. The supersensitivity of dopaminergic neurons to apomorphine in rats following chronic haloperidol.
Vogelsang GD; Piercey MF
Eur J Pharmacol; 1985 Apr; 110(2):267-9. PubMed ID: 3987817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
